Form 4 for CNMD CONMED Corp
Accepted 2023-06-02 00:00:00 ET · period of report 2023-06-01 · accession 0001127602-23-017622 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-06-02 | 2023-06-01 | CNMD | Farkas Charles | Dir | M - OptEx | $0.00 | +335 | 19.6K | +2% | $0 |
| D | 2023-06-02 | 2023-06-01 | CNMD | Farkas Charles | Dir | M - OptEx | $0.00 | -335 | 0 | -100% | $0 |
| DM | 2023-06-02 | 2023-06-01 | CNMD | Farkas Charles | Dir | A - Grant | $0.00 | +3,128 | 302 | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-06-01 | M | A | 335 | $0.00 | 19,578 | D | — | — | |
| 2 | Derivative | Rsus (restricted Stock Units) | 2023-06-01 | M | D | 335 | $0.00 | 0 | D | $0.00 · 2023-06-01 to 2032-06-01 | 335 Common Stock | (F1) Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2020 Amended and Restated Non-Employee Director Equity Compensation Plan, with the RSUs generally vesting 100% after a one year period. |
| 3 | Derivative | Options To Purchase Common Stock | 2023-06-01 | A | A | 2,826 | $0.00 | 2,826 | D | $123.79 · 2024-06-01 to 2033-06-01 | 2,826 Common Stock | (F2) The stock options were granted under the Company's 2020 Amended and Restated Non-Employee Director Equity Compensation Plan and generally vest 100% after a one year period. |
| 4 | Derivative | Rsus (restricted Stock Units) | 2023-06-01 | A | A | 302 | $0.00 | 302 | D | $0.00 · 2024-06-01 to 2033-06-01 | 302 Common Stock | (F1) Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2020 Amended and Restated Non-Employee Director Equity Compensation Plan, with the RSUs generally vesting 100% after a one year period. |